Publications by authors named "Ana Argibay"

Claim this Profile
S
Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure.
Mayka Freire, Bernardo Sopeña, Susana Bravo, Carlos Spuch, Ana Argibay

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis.
Mayka Freire, Bernardo Sopeña, Arturo González-Quintela, Alfredo Guillén Del Castillo, Eduardo Callejas Moraga, Ana Argibay

Autoimmun Rev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.
Patricia Fanlo, Borja Del Carmelo Gracia-Tello, Eva Fonseca Aizpuru, Jorge Álvarez-Troncoso, Andrés Gonzalez, Ana Belén Argibay

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Cristina Carbonell, Miguel Marcos, Alfredo Guillén-Del-Castillo, Manuel Rubio-Rivas, Ana Argibay

Autoimmun Rev· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry.
Andrés González García, Martin Fabregate, Luis Manzano, Alfredo Guillén Del Castillo, Manuel Rubio Rivas, Ana Argibay

Semin Arthritis Rheum· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, Berta Sáez Giménez, Dolores Colunga-Argüelles, Ana Argibay

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, Berta Sáez Giménez, Dolores Colunga-Argüelles, Ana Argibay

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].
Manuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, Carles Tolosa Vilella, Dolores Colunga Argüelles, Ana Argibay

Autoimmun Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, Alfredo Guillén-Del-Castillo, Dolores Colunga-Argüelles, Ana Argibay

Rheumatology (Oxford)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Manuel Rubio-Rivas, Xavier Corbella, Alfredo Guillén-Del-Castillo, Carles Tolosa Vilella, Dolores Colunga Argüelles, Ana Argibay

Autoimmun Rev· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Influence of age on the clinical manifestations of invasive pneumococcal disease and antibiotic resistance rates].
Maria Teresa Pérez-Rodríguez, Bernardo Sopeña, Susana Méndez-Lage, M de los Angeles Casares, Lucía Constenla, Ana Argibay

Med Clin (Barc)· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis